Extended fasciocutaneous flaps for autologous augmentation mastopexy with upper body lift after massive weight loss: an early experience.
Abstract
[INTRODUCTION] Common upper body findings after massive weight loss (MWL) include breast ptosis, projection loss, flattening, inframammary fold descent, and back rolls. Although implants address volume loss, manifestations of circumferential excess (ie, back rolls) are ignored. We review our experience with extended lateral fasciocutaneous flaps incorporating circumferential excess tissue, typically removed in upper body lifts (UBLs), for autologous augmentation mastopexy.
[METHODS] We reviewed all cases of simultaneous autoaugmentation mastopexy and UBL, using extended lateral chest wall fasciocutaneous flaps, performed after MWL. Donor sites were designed with scars residing within the bra line (UBL) or midaxillary line [modified UBL (mUBL)]. We analyzed demographics, clinical indications, and complications.
[RESULTS] Between 2007 and 2013, 7 patients underwent 13 extended fasciocutaneous flap reconstructions for autoaugmentation mastopexy, combined with UBL or mUBL. All patients underwent procedures with flaps taken from the back or from the midaxillary line. Mean initial body mass index (BMI) was 50.1 kg/m2 with a preoperative, post-MWL BMI of 28.5 kg/m2, weight loss of 58 kg, and BMI decrease of 21.6 kg/m2. Among 6 patients who underwent bariatric surgery, the average interval between gastric bypass and autoaugmentation mastopexy was 41 months. Five patients underwent these procedures for aesthetic reasons, whereas 2 patients underwent breast reconstruction. Follow-up averaged 18 months. Complications occurred in 3 patients, with only 1 requiring reoperation.
[CONCLUSIONS] Massive weight loss patients frequently present with breast volume loss and ptotic upper body soft tissue excess. Simultaneous mastopexy augmentation can be safely and reliably performed using extended fasciocutaneous flaps to autologously may be placed in aesthetically acceptable locations. Patients undergoing mUBLs with midaxillary line donor scars may conceal them with arms at their sides. Patients choosing back donor scars may conceal them within the bra line while having greater volumes available for augmentation. As is true with all flaps, one should assess distal tip perfusion before final inset, especially when using a flap extending to the midline back.
[METHODS] We reviewed all cases of simultaneous autoaugmentation mastopexy and UBL, using extended lateral chest wall fasciocutaneous flaps, performed after MWL. Donor sites were designed with scars residing within the bra line (UBL) or midaxillary line [modified UBL (mUBL)]. We analyzed demographics, clinical indications, and complications.
[RESULTS] Between 2007 and 2013, 7 patients underwent 13 extended fasciocutaneous flap reconstructions for autoaugmentation mastopexy, combined with UBL or mUBL. All patients underwent procedures with flaps taken from the back or from the midaxillary line. Mean initial body mass index (BMI) was 50.1 kg/m2 with a preoperative, post-MWL BMI of 28.5 kg/m2, weight loss of 58 kg, and BMI decrease of 21.6 kg/m2. Among 6 patients who underwent bariatric surgery, the average interval between gastric bypass and autoaugmentation mastopexy was 41 months. Five patients underwent these procedures for aesthetic reasons, whereas 2 patients underwent breast reconstruction. Follow-up averaged 18 months. Complications occurred in 3 patients, with only 1 requiring reoperation.
[CONCLUSIONS] Massive weight loss patients frequently present with breast volume loss and ptotic upper body soft tissue excess. Simultaneous mastopexy augmentation can be safely and reliably performed using extended fasciocutaneous flaps to autologously may be placed in aesthetically acceptable locations. Patients undergoing mUBLs with midaxillary line donor scars may conceal them with arms at their sides. Patients choosing back donor scars may conceal them within the bra line while having greater volumes available for augmentation. As is true with all flaps, one should assess distal tip perfusion before final inset, especially when using a flap extending to the midline back.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | mastopexy
|
유방성형술 | dict | 6 | |
| 해부 | breast
|
유방 | dict | 3 | |
| 시술 | flap
|
피판재건술 | dict | 2 | |
| 해부 | upper body lift
|
scispacy | 1 | ||
| 해부 | MWL
→ massive weight loss
|
scispacy | 1 | ||
| 해부 | circumferential
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | upper body lifts
|
scispacy | 1 | ||
| 해부 | line
|
scispacy | 1 | ||
| 해부 | midaxillary line
|
scispacy | 1 | ||
| 해부 | gastric
|
scispacy | 1 | ||
| 해부 | autologously
|
scispacy | 1 | ||
| 해부 | tip
|
코끝 | dict | 1 | |
| 합병증 | inframammary
|
scispacy | 1 | ||
| 합병증 | fasciocutaneous flap
|
scispacy | 1 | ||
| 합병증 | ptotic upper
|
scispacy | 1 | ||
| 합병증 | fasciocutaneous flaps
|
scispacy | 1 | ||
| 합병증 | flaps
|
scispacy | 1 | ||
| 합병증 | midline back
|
scispacy | 1 | ||
| 약물 | post-MWL
|
scispacy | 1 | ||
| 약물 | [INTRODUCTION] Common
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | weight loss
|
C1262477
Weight Loss
|
scispacy | 1 | |
| 질환 | MWL
→ massive weight loss
|
scispacy | 1 | ||
| 질환 | breast ptosis
|
C2233848
Ptosis of breast
|
scispacy | 1 | |
| 질환 | volume loss
|
scispacy | 1 | ||
| 질환 | breast volume loss
|
scispacy | 1 | ||
| 질환 | UBLs
→ upper body lifts
|
scispacy | 1 | ||
| 질환 | back donor
|
scispacy | 1 | ||
| 기타 | fasciocutaneous flaps
|
scispacy | 1 | ||
| 기타 | lateral fasciocutaneous flaps
|
scispacy | 1 | ||
| 기타 | wall fasciocutaneous flaps
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 |
MeSH Terms
Adult; Cosmetic Techniques; Fascia; Female; Humans; Mammaplasty; Middle Aged; Retrospective Studies; Skin Transplantation; Surgical Flaps; Weight Loss
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.